• Latest Posts
Interview 2 Sep 2020

An Alzheimer’s Vaccine Challenged the Consensus for 25 Years

Microbiome Therapies Threatened by Covid-19 Restrictions

Expert Advice 26 Aug 2020

Negotiating Early-Stage Biotech Valuation: VC vs Entrepreneur

What Does Unity’s Phase II Fail Mean for European Anti-Aging Research?

ADVERTISEMENT

Is Hepatitis D Healthcare Being Overlooked?

7 Biotech Books to Read in the Sun this Summer

Women’s Health Gains Traction as Bayer Pays €736M for UK Firm

CureVac Continues Covid-19 Vaccine Funding Frenzy with €180M IPO

Record Funding for Gene and Cell Therapy Accompanies Turbulent Times

Why are Some European Biotechs Going Public Without an IPO?

ADVERTISEMENT